New camera technique could spot hidden thyroid cancer

NCT ID NCT03484884

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new imaging method called Cerenkov luminescence imaging, which uses light naturally given off by certain radioactive substances used in standard cancer scans. Researchers want to see if this technique can take clear pictures of thyroid cancer and tumors that have spread to lymph nodes in the neck and other areas. About 102 adults with thyroid cancer or other tumors will be enrolled, and the goal is to achieve satisfactory images at least 80% of the time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Cerenkov luminescence imaging
What this could lead to
If successful, this could provide a new, non-invasive way to image thyroid cancer and other tumors, potentially improving detection of cancer spread.
What could go wrong
This is an early feasibility study with only 102 participants. The imaging method is still experimental and may not prove reliable enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10021, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.